March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT ​owner looks to ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.

OpenAI said on Thursday it will buy Python toolmaker Astral, as the ChatGPT maker seeks to strengthen its portfolio against rival Anthropic to gain more share in the artificial intelligence coding ...

OpenAI Group PBC today announced plans to acquire Astral Software Inc., a startup with a set of widely used Python development tools.  The terms of the deal were not disclosed. Astral’s development ...

University of Colorado Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain ...

From idea to live app in minutes: a straightforward, five-step way to start building with AI—no coding experience needed.

China's intense contest ecosystem meets India's grassroots coding grind in a record-setting global competition.

OpenAI, the leading artificial intelligence platform, has aimed to built a strong platform against Anthropic. The ChatGPT owner said on Thursday, March 20, 2026, it will acquire Python ...

With the acquisition of Python tool developer Astral, OpenAI is expanding its commitment in the coding sector and aims to further develop its Codex platform.

Due to their condition, the pythons were transported to a controlled environment," said U.S. Customs and Border Protection ...

ChatGPT maker OpenAI has announced the acquisition of open source developer tool startup Astral for an undisclosed sum, ...

PYTHON blood could hold the key to the next blockbuster weight loss treatment, scientists say. The reptiles can go months without eating after consuming a massive meal, while still remaining ...